• S&P 500: 1,342.64
  • Change: -0.69%
$0.40 -0.03 (-7.09%)
2/10/2012 4:00 PM

CEL-SCI Corp (AMEX:CVM)

CAPS Rating: 2 out of 5

The Company engages in the research and development of drugs and vaccines. Its most advanced product, Multikine, manufactured using the Company's proprietary cell culture technologies, is being developed for the treatment of cancer.

Current Price $0.40 Mkt Cap $85.00M
Open $0.42 P/E Ratio 0.00
Prev. Close $0.43 Div. (Yield) N/A (N/A)
Daily Range $0.38 - $0.42 Volume 10,268,493
52-Wk Range $0.27 - $0.76 Avg. Daily Vol. 0

News & Discussion Boards

More Headlines...

Sorry no news articles available for CVM.

Subject Recs Author Date

Caps

This ticker is not currently Ratable.

All Players

83 Outperform
9 Underperform
 

All-Star Players

15 Outperform
4 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top CVM Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.27)
Submitted June 13, 2011

I can already hear the gasps of horror. Yes, I meant to green thumb Cel-Sci. Even though the strategy has failed me horribly on stinkers like Hemispheryx, Rexahn, and Stemcells I still can't resist the temptation for the rebound play on CAPS. Welcome… More

DarthMaul09 (97.90)
Submitted October 16, 2009

Purely speculative bet that the 25% increase in stock price today was a bit excessive, although it was no were near the pop in had in August. I'm just a little pessimistic that the company can deliver a product worthy of the stock gain.

CVM VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about CVM.

Recs

1
Member Avatar zzlangerhans (99.27) Submitted: 6/13/2011 4:45:36 PM : Outperform Start Price: $0.54 CVM Score: -31.14

I can already hear the gasps of horror. Yes, I meant to green thumb Cel-Sci. Even though the strategy has failed me horribly on stinkers like Hemispheryx, Rexahn, and Stemcells I still can't resist the temptation for the rebound play on CAPS. Welcome to a world where commencing a study doesn't necessarily mean that a single patient has been enrolled. Neither does the study being "in progress". What exactly is happening at all those trial sites around the world is anyone's guess, but it doesn't seem to involve dosing patients with Multikine.

Despite my skepticism about Cel-Sci and their commencing, progressing, patient-less phase III trial I'm still willing to stick my virtual foot out as the share price touches the nine month low. Even if I ride this pick down to zero I'll still be amused by all the angry suckers that go down with me.

Recs

0
Member Avatar tighea (< 20) Submitted: 6/10/2011 1:04:35 PM : Outperform Start Price: $0.54 CVM Score: -31.41

No

Recs

2
Member Avatar Philyogy (64.27) Submitted: 1/20/2011 11:21:40 PM : Outperform Start Price: $0.75 CVM Score: -51.34

Looks great for a huge upswing this summer.. 2011

Leaderboard

Find the members with the highest scoring picks in CVM.

Score Leader

TMFBiologyFool

TMFBiologyFool (97.67) Score: +107.64

The Score Leader is the player with the highest score across all their picks in CVM.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
TMFBiologyFool 97.67 10/2/2009 Underperform 3W $1.71 -76.63% +31.01% +107.64 1 Comment
dexxyru < 20 9/24/2009 Underperform 5Y $1.59 -74.87% +27.85% +102.73 0 Comment
FoolsGrad 99.95 9/16/2009 Underperform NS $1.55 -74.23% +27.17% +101.39 0 Comment
DarthMaul09 97.90 10/16/2009 Underperform 5Y $1.55 -74.23% +23.49% +97.72 4 Comments
pennycruncher 80.64 10/19/2009 Underperform 5Y $1.52 -73.72% +23.19% +96.90 0 Comment
qasamm 63.47 1/3/2011 Underperform 3M $0.84 -52.41% +6.04% +58.45 0 Comment
bermuda999 25.28 8/16/2010 Underperform 1Y $0.50 -20.26% +24.91% +45.17 0 Comment
arboretum 28.82 6/14/2010 Underperform 5Y $0.50 -20.10% +21.57% +41.67 0 Comment
WxDog 75.92 3/28/2011 Underperform 5Y $0.57 -29.91% +2.11% +32.03 0 Comment
tddavis84 25.71 7/6/2011 Outperform 1Y $0.48 -16.77% +0.65% -17.42 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CVM.

Featured Broker Partners